Abolis Biotechnologies
Designs, Builds and Secure novel bio-processes for renewable chemical production with the help of engineered microbes.
- biotechnology
- sustainable development goals
- dt and ls
- woman founder
- climate tech
- radar de l'innovation
- tech for business
- observatoire industrial tech
- observatoire greentech
- observatoire deeptech
- biotech, medtech and e-health
- nif defense security and resilience
- clean industry
- observatoire healthtech
- synthetic biology
- greentech
- fermentation
- nif supply chain resilience
- nif materials and manufacturing
- biomanufacturing
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
* | €35.0m | Late VC | |
| Total Funding | 000k | ||
Related Content
Abolis is an industrial biotechnology company specializing in the development of bioproduction processes for chemical molecules via biomass fermentation. The company serves clients in the Chemical, Pharma, Cosmetic, and Food industries, addressing the challenge of producing ingredients and raw materials sustainably from economic, environmental, and societal perspectives. Abolis leverages its expertise in synthetic biology, informatics, robotics, fermentation, and analytical chemistry to create bio-based and clean alternatives to harmful chemicals. The business model revolves around providing tailored fermentation solutions that transform sugars into specific molecules of interest for their clients. Revenue is generated through project-based collaborations and the commercialization of proprietary bioprocess technologies.
Keywords: Industrial biotechnology, bioproduction, fermentation, biomass, sustainable, synthetic biology, chemical molecules, bio-based, environmental impact, tailored solutions.